UCSF Diabetic Foot Clinic
UCSF Diabetic Foot Clinical Research Unit
['FUNDING_U01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11257714
This UCSF program works with people who have diabetes and foot ulcers to collect samples and health information to find markers that help predict healing and prevent amputations.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11257714 on ClinicalTrials.gov |
What this research studies
At UCSF's Diabetic Foot Clinical Research Unit you would be seen for foot wounds and asked to allow sample collection (like blood and tissue), clinical exams, and surveys about your health and social circumstances. The unit is part of a national Diabetic Foot Consortium that runs multi-center biomarker validation trials, maintains a biorepository, and uses a master protocol to enroll people with new or early foot ulcers. Researchers will study biological markers, compare standard-of-care practices, and include social determinants of health to understand healing, recurrence, and risk of amputation. Participation may also involve ancillary studies and follow-up visits to track wound healing and outcomes.
Who could benefit from this research
Good fit: Adults with diabetes who currently have, are developing, or are at high risk for a diabetic foot ulcer are ideal candidates.
Not a fit: People without diabetes, those with non-diabetic foot wounds, or those needing immediate emergency surgical care are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, this work could help identify ulcers at highest risk and guide care that reduces slow healing, recurrence, and lower-leg amputations.
How similar studies have performed: Other biomarker studies have shown early promise but are not yet definitive, and the Diabetic Foot Consortium has already run two biomarker validation trials and established a biorepository.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CONTE, MICHAEL S — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: CONTE, MICHAEL S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.